NCT06744491

Brief Summary

The purpose of this study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan, between biological sexes, and with varying physical activity levels.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 20, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

December 20, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

December 20, 2024

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

December 16, 2024

Last Update Submit

December 16, 2024

Conditions

Keywords

anabolic sensitivityaginggrowth and developmentphysical activityskeletal musclestable isotopes

Outcome Measures

Primary Outcomes (1)

  • Amino acid oxidation and net protein balance

    Amino acid oxidation and net protein balance assessed by oral 1-13C Leucine tracer. Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 6h post-prandial measurement period.

    6 Hours

Study Arms (4)

Children

Children as defined by maturity offset via age from peak height velocity (aPHV \< -1.0 years).

Adolescent

Adolescents as defined by maturity offset via age from peak height velocity (aPHV -0.5 to +1.5 years)

Young Adults

Young adults as defined by chronological age between ages 18 - 35 years

Older Adults

Older adults as defined by chronological age between ages 60 - 80 years

Eligibility Criteria

Age8 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Convenience sample of individuals who qualify for the corresponding cohorts based on inclusion/exclusion criteria stated.

You may qualify if:

  • Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone)
  • Chronological age for Healthy Young (age: 18-35 years) or Older (age: 60-80 years) adults
  • Chronological age between 8 to 16 years, with maturity offset \< -1 year from age of Peak Height Velocity (aPHV) for children and between -0.5 to +1.5 years from aPHV in adolescent participants
  • BMI between normal to overweight (18.5 - 29.9 kg/m2)

You may not qualify if:

  • Regular use of nonsteroidal anti-inflammatory dugs (with the exception of daily low-dose aspirin)
  • use of anticoagulants
  • use of a walker, cane, or assistive walking device
  • infectious or gastrointestinal disease
  • inability to comply with study protocol (e.g., unable to track diet)
  • regular tobacco use
  • self-reported illicit drug use (e.g., growth hormone, testosterone, etc.)
  • diagnosed chronic illness (e.g., type 2 diabetes, heart disease, thyroid disease)
  • pregnant
  • hormonal replacement therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goldring Center for High Performance Sport

Toronto, Ontario, M5S 2C9, Canada

Location

Biospecimen

Retention: SAMPLES WITH DNA

Urine and saliva samples will be retained, though not for the purpose of DNA extraction.

MeSH Terms

Conditions

Sedentary BehaviorMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Central Study Contacts

Daniel R Moore, PhD

CONTACT

Hugo JW Fung, PhD Candidate

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Muscle Physiology

Study Record Dates

First Submitted

December 16, 2024

First Posted

December 20, 2024

Study Start

December 20, 2024

Primary Completion

May 30, 2025

Study Completion

August 31, 2025

Last Updated

December 20, 2024

Record last verified: 2024-11

Locations